NCT00215748View on ClinicalTrials.gov

Reduced Dexamethasone Pre-Medication Dose in Elderly Patients Receiving Weekly Docetaxel

PHASE2TerminatedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 31, 2004

Study Completion Date

April 30, 2007

Conditions
Breast CancerLung Cancer
Interventions
DRUG

Dexamethasone

Trial Locations (1)

21211

Baltimore

Sponsors

Collaborators (1)

Sanofi
All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

Geriatric Oncology Consortium

OTHER

NCT00215748 - Reduced Dexamethasone Pre-Medication Dose in Elderly Patients Receiving Weekly Docetaxel | Biotech Hunter | Biotech Hunter